Heart Failure NYHA Class III Clinical Trial
Official title:
Remission From Stage D Heart Failure (RESTAGE-HF)
The purpose of this study is to determine the proportion of subjects who have sufficient improvement in ventricular function after undergoing a standardized Left Ventricular Assist Device (LVAD) plus pharmacologic recovery treatment and testing protocol to allow removal of the LVAD within 18 months.
The encouraging results from the LVAD based recovery series suggest that the significant hemodynamic unloading provided by the Mechanical Circulatory Support (MCS) in conjunction with aggressive pharmacological treatment may induce a profound reverse structural remodeling and in turn result in a curative alternative to a specific patient population with severe heart failure. The active identification and characterization of the patients with a high potential for full cardiac function recovery is of paramount importance. The development of a standard and simplified recovery protocol would ultimately lead to a larger bridge to recovery patient population. The primary objective of this study is to determine the proportion of subjects who have sufficient improvement in ventricular function (remission from heart failure) after undergoing a standardized LVAD plus pharmacologic recovery treatment and testing protocol to allow removal of the LVAD within 18 months. The secondary objectives of this study are twofold, first to determine the durability of sustained remission from HF following LVAD explantation at 12 months and up to 3 years and second to determine the predictors of recovery. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04452149 -
Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure
|
N/A | |
Not yet recruiting |
NCT06097481 -
Narrative Intervention for Chronic Illness- Heart Failure Trial (NICI-HF)
|
Phase 1/Phase 2 | |
Withdrawn |
NCT03005184 -
Mechanism(s) Underlying Cardiovascular Effects of ARB/NEP Inhibition - Aim 2
|
Phase 2 | |
Not yet recruiting |
NCT01669395 -
Severe Heart Failure and Homebased Rehabilitation - An Intersectoral Randomized Controlled Trial
|
N/A | |
Completed |
NCT05835063 -
A Study to Improve Physician-Youth Communication and Medical Decision Making
|
N/A | |
Completed |
NCT03895073 -
HEart fAiluRe evaluaTion Questionnaire
|
||
Completed |
NCT03095196 -
Multipolar CRT-d and Diabetes
|
N/A | |
Recruiting |
NCT03180320 -
Baduanjin-eight-silken-movement With Self-efficacy Building for Patients With Chronic Heart Failure (BESMILE-HF Study)
|
N/A | |
Completed |
NCT06233695 -
Gender-based Differences in the Outcome of Treatment With Aldosterone Antagonists in Patients With Heart Failure
|
||
Withdrawn |
NCT03947853 -
Clinical Study to Evaluate the Predictive Value of the Heart Failure Questionnaire (HF-Q) for the Occurrence of Μajor Αdverse Cardiovascular Events (MACE) in Patients With Symptomatic Heart Failure
|
||
Recruiting |
NCT05934487 -
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
|
N/A | |
Recruiting |
NCT04829617 -
Promoting Well-being and Health in Heart Failure
|
N/A | |
Recruiting |
NCT03538990 -
Effect of DASH Eating Pattern on Heart Failure Outcomes
|
N/A | |
Recruiting |
NCT05487365 -
Implementation and Cost-evaluation of a Smartphone-based Telemonitoring and Digital Support in Patients With HF
|
N/A | |
Completed |
NCT03592836 -
Diuretic Response in Advanced Heart Failure: Bolus Intermittent vs Continuous INfusion
|
Phase 3 | |
Completed |
NCT01560871 -
Effects of a Walking Program and Inspiratory Muscle Training in Individuals With Chronic Heart Failure
|
N/A | |
Completed |
NCT03387813 -
Hemodynamic-GUIDEd Management of Heart Failure
|
N/A | |
Not yet recruiting |
NCT06270875 -
Addressing Pain Through Navigator-Led Palliative Care Optimized for Heart Failure (ADAPT-HF)
|
N/A | |
Enrolling by invitation |
NCT05885607 -
Early Metabolic Adaptations to SGLT2 Inhibition in Heart Failure
|
||
Active, not recruiting |
NCT04012944 -
SIRONA 2 Trial Heart Failure NYHA Class III
|
N/A |